Showing results (521-530 of 612) with videos related to
Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 5, 2020
White matter lesion location correlates with disability in relapsing multiple sclerosisLaura Gaetano, Baldur Magnusson, Petya Kindalova, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 6, 2020
HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohortMaria Gontika, Charalampos Skarlis, Artemios Artemiadis, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 25, 2020
Cost-efficiency of specialist inpatient rehabilitation for adults with multiple sclerosis: A multicentre prospective cohort analysis of the UK Rehabilitation Outcomes Collaborative national clinical dataset for rehabilitation centres in EnglandLynne Turner-Stokes, Richard Harding, Peihan Yu, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 5, 2019
ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factorItziar Lopetegi, Amaia Muñoz-Lopetegi, Maialen Arruti, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 13, 2020
High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trialJan Dörr, Priscilla Bäcker-Koduah, Klaus-Dieter Wernecke, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2019
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial resultsRobert T Naismith, Barry Hendin, Sibyl Wray, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2019
Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?Lisa Eunyoung Lee, Jillian K Chan, Emilie Nevill, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Updated diagnostic criteria for neuromyelitis optica spectrum disorder: Similar outcomes of previously separate cohortsM McCreary, M A Mealy, D M Wingerchuk, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 4, 2020
PARP-1 deregulation in multiple sclerosisMaria Meira, Claudia Sievers, Francine Hoffmann, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 14, 2020
Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in FranceAlice Guilleux, Jonathan Roux, David Travers, et al.Pageof 62